Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New opioid aims to ease pain without slowing digestion after spine surgery

NCT ID NCT07307495

First seen Jan 04, 2026 · Last updated May 21, 2026 · Updated 19 times

Summary

This study tests a new painkiller called oliceridine fumarate in 428 adults having lumbar spine surgery. The goal is to see if it controls pain as well as standard opioids but with fewer side effects like constipation and breathing problems. Participants will be randomly assigned to receive either oliceridine or a placebo after surgery, and researchers will track how quickly their digestion returns to normal.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OLICERIDINE FUMARATE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.